Administration of Neomycin Resistance Gene Marked EBV Specific Cytotoxic T-Lymphocytes to Patients with Relapsed EBV-Positive Hodgkin Disease. Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas
- 20 May 1998
- journal article
- clinical trial
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 9 (8) , 1237-1250
- https://doi.org/10.1089/hum.1998.9.8-1237
Abstract
The only peer-reviewed journal focused on the rapidly moving field of 3D printing and related technologies, providing comprehensive coverage of academic research and industrial and commercial developments that have applications in medicine, education, food, and architecture.Keywords
This publication has 2 references indexed in Scilit:
- Control mechanisms of Epstein-Barr virus persistenceSeminars in Virology, 1994
- Epstein-Barr virus strategy in normal and neoplastic B cellsCell, 1994